151Basiliximab (Simulect ®) is safe and well tolerated in adult liver transplantation and provides a low rate of acute rejection
Titel:
151Basiliximab (Simulect ®) is safe and well tolerated in adult liver transplantation and provides a low rate of acute rejection
Auteur:
Calmus, Y. Scheele, J. Gonzalez-Pinto Arrillaga, I. Jaurriela Mas, E. Klar, E. Pageaux, G. Scudamore, C. Cuervas-Mons Martinez, V. Metselaar, H.J. Girault, D.
Verschenen in:
Liver transplantation
Paginering:
Jaargang 6 (2000) nr. 3 pagina's 1 p.
Jaar:
2000
Inhoud:
Uitgever:
American Association for the Study of Liver Diseases